medical malpractice

Episiotomy Complications After Childbirth

Published on: September 19, 2019 | Levin & Perconti

med mal attorney

Episiotomy Complications After Childbirth

As more women speak up about their pregnancy challenges, share delivery stories and post-partum struggles, many are starting to let their doctors know that the unnecessary episiotomy they performed during childbirth has created lasting injuries and made sexual intercourse painful if not impossible. The American Pregnancy Association identifies these situations in which an episiotomy may be needed for any of the following reasons:

Birth is imminent and the perineum hasn’t had time to stretch slowly

Medical Device Risks Finally Revealed By FDA

Published on: July 2, 2019 | Levin & Perconti

product liability lawyers

FDA Releases 20 Years of “Hidden” Data Related to Medical Device Injuries and Deaths

Serious medical complications and lifelong injuries, and even death, can result from a risky or wrong medical device. But a March 8, 2019 Kaiser Health News investigative report has led to the recent Food and Drug Administration (FDA) release of two decades worth of previously hidden data containing millions of malfunctions by medical devices and allowed some manufacturers to keep potential safety issues quiet.

Some of the FDA’s public reporting of adverse device outcomes were previously filed as an “alternative summary,” and included more than 5.7 million incidents hidden from the American people. This is risk information that could have been (and now will be) helpful for device prescribing doctors, medical researchers and life-saving knowledge for consumers and patients.

Surgical Mesh Injuries To Women

Published on: April 22, 2019 | Levin & Perconti

medical malpractice attorneys

FDA Says Surgical Mesh Manufacturers Must Stop Selling Unsafe Devices

On April 16, 2019, The U.S. Food and Drug Administration (FDA) ordered two manufacturers of three different vaginal mesh products to immediately stop selling and distributing their products for not meeting U.S. premarket standards for high risk devices. The FDA also said there was insufficient evidence that the mesh worked better than surgery to repair pelvic organ prolapse (POP).

The three vaginal mesh devices are: